METHOD FOR PREDICTING THE CLINICAL COURSE OF AFFECTIVE DISORDER IN BIPOLAR AND MONOPOLAR DEPRESSIVE TYPE BASED ON DETERMINATION OF BLOOD SERUM PROTEINS
2024-10-24
专利权人AS RUSSIA TOMSK NAT RES MEDICAL CENT (ASTO-Non-standard)
申请日期2024-10-24
专利号RU2835348-C1
成果简介NOVELTY - Invention refers to medicine, namely to psychiatry, and can be used for prediction of the course of affective disorder by bipolar and monopolar depressive type on the basis of blood serum protein determination. Content of S100B protein and neuron-specific enolase NSE in blood serum of the patients is determined before the beginning of therapy. If the S100B protein content is below 13.8 pg/ml and the NSE content is above 3.94 mcg/l, a bipolar course of affective disorder is predicted. USE - Medicine. ADVANTAGE - Method provides the possibility of predicting the course of the affective disorder in the bipolar and monopolar depressive type to increase the accuracy of diagnosis and for selecting the optimal psychopharmacotherapeutic approach to treating the affective pathology, by determining S100B protein concentrations in combination with the NSE content in blood serum, reflecting astrocytic and neuronal changes promoting the development, progression and outcome of affective disorder. 1 cl, 2 tbl, 2 ex
IPC 分类号G01N-033/573 ; G01N-033/68
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/14772
专题中国科学院新疆生态与地理研究所
作者单位
AS RUSSIA TOMSK NAT RES MEDICAL CENT (ASTO-Non-standard)
推荐引用方式
GB/T 7714
LEVCHUK L A,ROSHCHINA O V,SIMUTKIN G G,et al. METHOD FOR PREDICTING THE CLINICAL COURSE OF AFFECTIVE DISORDER IN BIPOLAR AND MONOPOLAR DEPRESSIVE TYPE BASED ON DETERMINATION OF BLOOD SERUM PROTEINS. RU2835348-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。